Structure leukotrienes

Despite these uncertainties, several groups set out to prepare the proposed leukotriene structures, and during these syntheses some interesting observations were made with respect to the double-bond stereochemistry which eventually lead to modification of the proposed structures for LTA4 and LTC4. These observations are outlined here in a historical context to indicate their contribution to the final structure proof of the leukotrienes. 

The first SRS-A antagonistj FPL-55712 (26) (149), was discovered before the structures of the leukotrienes were deterrniaed. Although this compound is relatively weak as an antagonist and suffers from a very short half-hfe m vivo, it played an important role both iu leukotriene structure elucidation and as a model for later antagonists. In work stmcturaUy related to FPL-55712, LY-171883 was developed (27) (150). LY-171883 was evaluated in several clinical trials before development was stopped. Orally administered, LY-171883 blocked slightly the response to aerosol LTD improved pulmonary function (FEV ) in mild asthmatics (151), decreased the sensitivity of asthmatics to cold air-induced bronchoconstriction (152), and significandy reduced the bronchoconstrictor response to inhaled antigen (153). However, in all these studies the beneficial effects were minimal. 

Ninnetnatm, JL. (1988) Prostaglandins, Leukotrienes and the Immune Responses, in Prostaglandin/Leukotriene Structure and Chemistry, pp. 12-26, Cambridge University Press, Cambridge. 

The carbon sulfur bond in LTC4 is formed by the reaction of glutathione (Section 15 13) with leukotriene A4 (LTA4) LTA4 is an epoxide Sug gest a reasonable structure for LTA4... 

The organization of Part Two is according to structural type. The first section, Chapter Seven, is concerned with the synthesis of macrocyclic compounds. Syntheses of a number of heterocyclic target structures appear in Chapter Eight. Sesquiterpenoids and polycyclic higher isoprenoids are dealt with in Chapters Nine and Ten, respectively. The remainder of Part Two describes syntheses of prostanoids (Chapter Eleven) and biologically active acyclic polyenes including leukotrienes and other eicosanoids (Chapter Twelve). 

FIGURE 9.20 Design of multiple ligancl activity, (a) Dual histamine HI receptor and leukotriene receptor antagonist incorporating known antihistaminic properties of cyproheptadine and LTD4. (b) Joint ACE/NEP inhibitor formed from incorporating similarities in substrate structures for both enzymes. From [57],... 

Rats fed a purified nonlipid diet containing vitamins A and D exhibit a reduced growth rate and reproductive deficiency which may be cured by the addition of linoleic, a-linolenic, and arachidonic acids to the diet. These fatty acids are found in high concentrations in vegetable oils (Table 14-2) and in small amounts in animal carcasses. These essential fatty acids are required for prostaglandin, thromboxane, leukotriene, and lipoxin formation (see below), and they also have various other functions which are less well defined. Essential fatty acids are found in the stmctural lipids of the cell, often in the 2 position of phospholipids, and are concerned with the structural integrity of the mitochondrial membrane. 

Eosinophils may be increased in some patients, particularly during exacerbations. Activated inflammatory cells release a variety of mediators, most notably leukotriene B4, interleukin-8, and tumor necrosis factor-a (TNF-a). Various proteinases, such as elastase, cathepsin G, and proteinase-3, are secreted by activated neutrophils. These mediators and proteinases are capable of sustaining inflammation and damaging lung structures. 

Soon after, the complete structure of SRS-A was finally determined by total synthesis. SRS-A turned out to be a mixture of 3 substances now known as leukotriene C4 (LTC4), leukotriene D4 (LTD4) and leukotriene E4 (LTE4) in which LTD4 was predominant. The jump from a biological observation in 1938 to a molecular structure of LTD4 opened the door to a novel and selective treatment for asthma. The theory was that if one... 

The structure-activity relationships for thiourea derivatives have been investigated as vanilloid receptor antagonist,216 220 and mast cell leukotriene release, etc.221 224... 

Lipids have multiple roles in cells. Recent discoveries show that the same lipid may have both structural and regulatory roles in the cell. For example, while arachidonic acid (20 4co6) is a major constituent of brain inositides and PtdEtn, the free acid is also a precursor of a number of important bio messengers, the eicosanoids, such as prostaglandins, prostacyclins, leukotrienes and thromboxanes... 

Stimulation of free nerve endings known as nociceptors is the first step leading to the sensation of pain. These receptors are found in both somatic and visceral structures and are activated by mechanical, thermal, and chemical factors. Release of bradykinins, K1, prostaglandins, histamine, leukotrienes, serotonin, and substance P may sensitize and/or activate nociceptors. Receptor activation leads to action potentials that are transmitted along afferent nerve fibers to the spinal cord. 

Dietary polyunsaturated fatty acids (PUFAs), especially the n-3 series that are found in marine fish oils, modulate a variety of normal and disease processes, and consequently affect human health. PUFAs are classified based on the position of double bonds in their lipid structure and include the n-3 and n-6 series. Dietary n-3 PUFAs include a-linolenic acid, eicosapentaenoic acid (EPA), and docosahexaenoic acid (DHA) whereas the most common n-6 PUFAs are linoleic acid, y-linolenic acid, and arachidonic acid (AA). AA is the primary precursor of eicosanoids, which includes the prostaglandins, leukotrienes, and thromboxanes. Collectively, these AA-derived mediators can exert profound effects on immune and inflammatory processes. Mammals can neither synthesize n-3 and n-6 PUFAs nor convert one variety to the other as they do not possess the appropriate enzymes. PUFAs are required for membrane formation and function... 

Fig. 8.2 Alignment of the protein structure of the cysteinyl leukotriene 1 (CysLTj) and 2 (CysLT ) receptors in relation to rhodopsin. The amino acids conserved between these family A receptors are shown. The consensus is greater than 50%. These data formed the basis of the model predicting the CysLTj and CysLT transmembrane domains (helices 1-7), the four [3-sheets, and the putative cysteinyl leukotiiene-binding domain. The amino acid variants that are associated with atopy or asthma, the G300S CysLTj variant, and the M201V CysLT variant are each boxed and noted with arrows...

The fats also have a plastic function as they are included in cell membranes and other cell structures. The central and peripheral nervous systems are rich in lipids. PNFA are included in cell membranes, with their most significant function being the synthesis of cell hormones — prostaglandins. The properties of cell membranes as well as their interaction with external factors depend on the relation of PNFA concentration in cell components. In humans, prostaglandins are created not only in tissues but also in thrombocytes (thromboxanes) and in leucocytes (leukotrienes). The biological action of thrombocytes is extremely variant and depends on PNFA type which are the basis for fatty acid creation. 

This assay procedure has been applied to various haptens having a primary amino group, including leukotriene C4 (VI), T4 (P2), substance P (P2), endothelin (P2), and AGII (G2) (for structures, see Fig. 5A and 5C). These noncompetitive assays were 10-300-fold more sensitive than corresponding competitive assays (G2). The minimal detectable concentrations described in these papers were as follows 2 pg/ml ( 0.3 fmol/assay) for leukotriene C4, 14 pg/ml ( 0.2 fmol/assay) for T4, 6 pg/ml ( 0.4 fmol/assay) for substance P, and 20 pg/ml ( 0.8 fmol/assay) for endothelin. 

D. A. Clark, A. Marfat (1982). Structure elucidation and the total synthesis of leukotrienes. Annu. Rep. Med. Chem. 17 291-300. 

The structure of the leukotrienes receptor antagonist cinalukast (58-9) bears only the vaguest resemblance to its predecessor, or, for that matter, to a leukotriene. Reaction of the cyanomethylphosphonate (58-1) with hydrogen sulfide converts the nitrile to a thioamide (58-2). Treatment of that intermediate with the bromoketone... 

The antiasthamtic activity of the sulfur-free substituted long chain fatty acid seratrodast (59-5) is attributed to the antagonism of thromboxanes, whose structures also include a fatty side chain, rather than to leukotrienes. Friedel-Crafts acylation of benzene with the acid chloride from monomethyl pimelate (59-1) leads to... 

A Palauan species of Dysidea contained 15-acetylthioxyfurodysinin lactone (327), that binds to human leukotriene B4 (LTB4) receptor. The structure was determined by spectral data analysis and confirmed by synthesis involving photo-oxidation of 15-acetylthioxyfurodysinin (328), which co-occurs with it in the sponge [297,298]. An Australian species of Euryspongia also contained 15-acetylthioxyfurodysin (329) and 15-acetylthioxyfurodysinin (328) [299]. A sample of D. herbacea from the Great Barrier Reef contained (-)-neodysidenin (330) and the absolute configuration was determined by capillary electrophoresis of Marfey s derivatives [300]. 

---